On-Q* Pump With Select-A-Flow* Variable Rate Controller - Halyard ON-Q Instrucciones De Uso

ON-Q* Pump with SELECT-A-FLOW* Variable Rate Controller

• e n
Instructions for Use
Important Information
Please read the entire document before operating the
ON-Q* device. Follow all instructions carefully to ensure
the safety of patient and/or user.
User Information
• For 24-hour Product Support, call 800-444-2728 or
+1-949-923-2400 (English only).
• Visit www.halyardhealth.com or contact your sales
representative for the latest product information and
Technical Bulletins (English only), including but not
limited to:
• ON-Q* with SELECT-A-FLOW*, Drug Dosing
Information Technical Bulletin
• Use of ON-Q* Pump in Magnetic Resonance (MR)
environment
• Latex Sensitivity
• Continuous Infusion in Pediatric Patients
• Use of ON-Q* Pump in Hand and Foot Surgery
Volume and Flow Rate Selection
• What We Know About Chondrolysis Today
• Use of ON-Q* with Perioperative Autologous Blood
Transfusion Systems
• USP 797
• Effect of Storage Times on Flow Rate on Pre-filled
ON-Q* Elastomeric Pumps
• Patient Guidelines
Warning
Flow rate is adjustable. Medication dosage should be
based on maximum flow rate. To reduce potential
adverse events:
• Medication dosing should be based on the
maximum flow rate (7 or 14 ml/hr).
• The amount of medication over the therapeutic
period and delivery time can vary by as much as
20%. Take this variance into consideration when
determining medication delivery.
• Regardless of the prescribed flow rate,
only fill the pump with medication dosage that
is appropriate to administer at the maximum
flow rate.
• Due to risk of ischemic injury, vasoconstrictors
such as epinephrine are not recommended for
continuous infusions for the following routes of
administration: intraoperative site, perineural and
percutaneous (excluding epidural).
• Medications or fluids must be administered per
instructions provided by the drug manufacturer.
Physician is responsible for prescribing drug based
on each patient's clinical status (such as age, body
weight, disease state of patient, concomitant
medications, etc.).
• There is no alarm or alert when flow interruption
occurs, therefore, life-supporting medications
whose usage may cause serious injury or death
due to stoppage or under-delivery are not
recommended for infusion with the ON-Q* device.
• There is no indicator of pump infusion status,
therefore, use caution where over-delivery of
medications could result in serious injury or death.
• Epidural infusion of analgesics is limited to uses
of indwelling catheters specifically designed for
epidural delivery. To prevent infusion of drugs not
indicated for epidural use, do not use IV set with
additive ports. It is strongly recommended that
devices used for administration of medication via
epidural routes be clearly differentiated from all
other infusion devices.
• To avoid complications, use the lowest flow rate,
volume and drug concentration required to produce
the desired result. In particular:
• Avoid placing the catheter in the distal end of
extremities (such as fingers, toes, nose, ears,
penis, etc.) where fluid may build up as this may
lead to ischemic injury or necrosis.
• Avoid placing the catheter in joint spaces.
Although there is no definitive established
causal relationship, some literature has shown
a possible association between continuous
intra-articular infusions (particularly with
bupivacaine) and the subsequent development
of chondrolysis.
• Avoid tight wrappings which can limit blood
supply or fluid diffusion.
3